Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries

IRVINE, Calif., July 15, 2020 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received... Devices, Cardiology, Surgery, FDA Edwards Lifesciences, KONECT RESILIA, aortic valved conduit
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news